Pulmonary Atresia Diagnostics and Treatment Market Type (Intact Ventricular Septum, Ventricular Septum Defect), Diagnosis (Pulse Oximetry, Echocardiogram), Treatment (Medication, Surgery), End-Users (Hospitals, Clinics)–Global Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Pulmonary Atresia Diagnostics and Treatment Market, by Type

6.1 Introduction

6.2 Pulmonary atresia with intact ventricular septum

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.3 Pulmonary atresia with ventricular septum defect

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 7. Global Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis

7.1 Introduction

7.2 Pulse oximetry

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3 Electrocardiogram (ECG)

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.4 Echocardiogram (cardiac ultrasound)

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.5 Cardiac MRI

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.6 Cardiac catheterization

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 8. Global Pulmonary Atresia Diagnostics and Treatment Market, by Treatment

8.1 Introduction

8.2 Medication

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.3 Cardiac catheterization

8.3.1 Radiofrequency ablation

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.3.2 Balloon valvotomy

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.3.3 Balloon atrial septostomy

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.3.4 Stent placement

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4 Surgery

8.4.1 Right ventricular outflow reconstruction

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4.2 Blalock-Taussig Shunt

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4.3 Bi-directional Glenn procedure

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4.4 Fontan procedure

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4.5 Heart transplant

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 9. Global Pulmonary Atresia Diagnostics and Treatment Market, by End-Users

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

9.3 Clinics

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

9.4 Diagnostic centers

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

9.5 Specialty Clinics

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

9.6 Research Institutes

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

9.7 Others

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 10. Global Pulmonary Atresia Diagnostics and Treatment Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Kyowa Pharma Chemical Co. Ltd

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Abbott Laboratories

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

10.2.5 SWOT Analysis

12.3 AZAD partners

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Dickinson and Company

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Becton

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 C. R. Bard, Inc.

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 B. Braun Melsungen AG

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Medtronic plc.

12.8.1 Overview

12.8.2 Type/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Teleflex Incorporated

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 JOHNSON & JOHNSON

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Cook Group Incorporated

12.11.1 Overview

12.11.2 Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Boston Scientific Corporation

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Biosurgery Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Pulmonary Atresia Diagnostics and Treatment Market Synopsis, 2023–2030

Table 2 Global Pulmonary Atresia Diagnostics and Treatment Market Estimates and Forecast, 2023–2030 (USD Million)

Table 3 Global Pulmonary Atresia Diagnostics and Treatment Market, by Region, 2023–2030 (USD Million)

Table 4 Global Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 5 Global Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 6 Global Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 7 Global Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 8 North America: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD

Million)

Table 9 North America: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 10 North America: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 11 North America: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 12 US: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 13 US: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 14 US: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 15 US: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 16 Canada: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 17 Canada Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 18 Canada: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 19 Canada: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 20 South America: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 21 South America: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 22 South America: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 23 South America: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 24 Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 25 Europe Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 26 Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 27 Europe: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 28 Western Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 29 Western Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 30 Western Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 31 Western Europe: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 32 Eastern Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 33 Eastern Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 34 Eastern Europe: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 35 Eastern Europe: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 36 Asia-Pacific: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 37 Asia-Pacific: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 38 Asia-Pacific: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 39 Asia-Pacific: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Table 40 Middle East & Africa: Pulmonary Atresia Diagnostics and Treatment Market, by Type, 2023–2030 (USD Million)

Table 41 Middle East & Africa: Pulmonary Atresia Diagnostics and Treatment Market, by Diagnosis, 2023–2030 (USD Million)

Table 42 Middle East & Africa: Pulmonary Atresia Diagnostics and Treatment Market, by Treatment, 2023–2030 (USD Million)

Table 43 Middle East & Africa: Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for the Global Pulmonary Atresia Diagnostics and Treatment Market

Figure 3 Segmentation Market Dynamics for the Global Pulmonary Atresia Diagnostics and Treatment Market

Figure 4 Global Pulmonary Atresia Diagnostics and Treatment Market Share, by Type, 2023

Figure 5 Global Pulmonary Atresia Diagnostics and Treatment Market, by End-users, 2023–2030 (USD Million)

Figure 6 Global Pulmonary Atresia Diagnostics and Treatment Market Share, by Region, 2023

Figure 7 North America: Pulmonary Atresia Diagnostics and Treatment Market Share, by Country, 2023

Figure 8 Europe: Pulmonary Atresia Diagnostics and Treatment Market Share, by Country, 2023

Figure 9 Asia-Pacific: Pulmonary Atresia Diagnostics and Treatment Market Share, by Country, 2023

Figure 10 Middle East & Africa: Pulmonary Atresia Diagnostics and Treatment Market Share, by Country, 2023

Figure 11 Global Pulmonary Atresia Diagnostics and Treatment Market: Company Share Analysis, 2023 (%)

Figure 12 Kyowa Pharma Chemical Co. Ltd: Key Financials

Figure 13 Kyowa Pharma Chemical Co. Ltd: Segmental Revenue

Figure 14 Kyowa Pharma Chemical Co. Ltd: Geographical Revenue

Figure 15 Abbott Laboratories: Key Financials

Figure 16 Abbott Laboratories: Segmental Revenue

Figure 17 Abbott Laboratories: Geographical Revenue

Figure 18 AZAD partners: Key Financials

Figure 19 AZAD partners: Segmental Revenue

Figure 20 AZAD partners: Geographical Revenue

Figure 21 Dickinson and Company: Key Financials

Figure 22 Dickinson and Company: Segmental Revenue

Figure 23 Dickinson and Company: Geographical Revenue

Figure 24 Becton: Key Financials

Figure 25 Becton: Segmental Revenue

Figure 26 Becton: Geographical Revenue

Figure 27 C. R. Bard, Inc.: Key Financials

Figure 28 C. R. Bard, Inc.: Segmental Revenue

Figure 29 C. R. Bard, Inc.: Geographical Revenue

Figure 30 B. Braun Melsungen AG: Key Financials

Figure 31 B. Braun Melsungen AG: Segmental Revenue

Figure 32 B. Braun Melsungen AG: Geographical Revenue

Figure 33 Medtronic plc.: Key Financials

Figure 34 Medtronic plc.: Segmental Revenue

Figure 35 Medtronic plc.: Geographical Revenue

Figure 36 Teleflex Incorporated: Key Financials

Figure 37 Teleflex Incorporated: Segmental Revenue

Figure 38 Teleflex Incorporated: Geographical Revenue

Figure 39 JOHNSON & JOHNSON: Key Financials

Figure 40 JOHNSON & JOHNSON: Segmental Revenue

Figure 41 JOHNSON & JOHNSON: Geographical Revenue

Figure 42 Cook Group Incorporated: Key Financials

Figure 43 Cook Group Incorporated: Segmental Revenue

Figure 44 Cook Group Incorporated: Geographical Revenue

Figure 45 Boston Scientific Corporation: Key Financials

Figure 46 Boston Scientific Corporation: Segmental Revenue

Figure 47 Boston Scientific Corporation: Geographical Revenue